PDI Announces New Business Win With New Customer to Promote Rx Derm Therapy

PDI, Inc. PDII today announced a two-year contract sales engagement with a new pediatric dermatology customer to promote a first-line prescription dermatology product. The agreement is expected to run until September 2013 and generate approximately $5 million in revenues to PDI over the life of the contract, with approximately $1 million to be recorded in 2011. Under the agreement, PDI will provide a dedicated sales team that will call on pediatricians and dermatologists.